Analytical relationships among Biosite, Bayer, and Roche methods for BMP and NT-proBNP A preliminary study

American Journal of Clinical Pathology

Volumn 123, Issue 4, 2005, Pages 584-590

  Sykes, Elizabeth ^a   Karcher, Raymond E ^a   Eisenstadt, Janice ^a   Tushman, David A ^a   Balasubramaniam, Mamtha ^a   Gusway, John ^a   Peterson, Valerie J ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

B type natriuretic peptide; Heart failure; NT pro BMP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE; PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; EMERGENCY HEALTH SERVICE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PATIENT MONITORING; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY;

EID: 15744396037     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/F86FVEFDGX06DTUV     Document Type: Article

References (28)

1. Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide: its function and diagnostic application. Clin Biochem Rev. 2002;23:3-21.
2. Luchner A, Hengstenberg C, Lowel H, et al. N-terminal pro-brain natriuretic peptide after myocardial infarction. Hypertension. 2002;39:99-104.
3. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic (BNP) peptide testing. Eur Heart J. 2003;24:1710-1718.
4. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation. 2002;106:416-422.
5. Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202-209.
6. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126-1130.
7. De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014-1021.
8. Ishii J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol. 2002;89:691-695.
9. McCullough PA, Due P, Omland T, et al, and the Breathing Not Properly Multinational Study Investigators. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis. 2003;41:571-579.
10. Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology. 2000;93:19-25.
11. Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141:367-374.
12. Wu AHB, Packer M, Smith A, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-Type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem. 2004;50:867-873.
13. Fischer Y, Filzmaier K, Stiegler H, et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem. 2001;47:591-594.
14. Yeo K-TJ, Wu AHB, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta. 2003;338:107-115.
15. Kemperman H, van den Berg M, Kirkels H, et al. B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a ventricular assist device. Clin Chem. 2004;50:1670-1672.
16. Alehagen U, Lindstedt G, Eriksson H, et al. Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care. Clin Chem. 2003;49:1337-1346.
17. Roche. Elecsys 2010 assay [package insert]. Indianapolis, IN: Roche; 2002.
18. Bayer Diagnostics. Centaur assay [package insert]. Tarrytown, NY: Bayer Diagnostics; 2003.
19. Shimizu H, Aono K, Masuta K, et al. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta. 1999;285:169-172.
20. Shimizu H, Aono K, Masuta K, et al. Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system. Clin Chim Acta. 2001;305:181-186.
21. Wu AHB, Smith A, Wieczorek S, et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol. 2003;92:628-631.
22. Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J. 2002;144:834-839.
23. Harrison A, Bhalla V, Gardetto N, et al. Evolving use of B-type natriuretic peptide in clinical practice [letter]. Clin Chem. 2004;50:1714-1715.
24. Lee S, Stevens T, Sandberg S, et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail. 2002;8:149-154.
25. Belenky A, Smith A, Zhang B, et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin Chim Acta. 2004;340:163-172.
26. Cataliotti A, Malatino L, Jougasaki M, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc. 2001;76:1111-1119.
27. Puschendorf B, Mair J. Cardiac diseases. In: Thomas L, ed. Clinical Laboratory Diagnostics: Use and Assessment of Clinical Laboratory Results. Frankfurt, Germany: TH Books; 1998:101-119.
28. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide in an elderly population. J Intern Med. 1997;242:307-311.